Goldman Sachs’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.7M | Buy |
|
|||||
|
2025
Q1 | $19.7M | Buy |
|
|||||
|
2024
Q4 | $13.2M | Buy |
|
|||||
|
2024
Q3 | $9.44M | Sell |
|
|||||
|
2024
Q2 | $15.6M | Buy |
|
|||||
|
2024
Q1 | $8.69M | Sell |
|
|||||
|
2023
Q4 | $19.3M | Buy |
|
|||||
|
2023
Q3 | $15.3M | Buy |
|
|||||
|
2023
Q2 | $7.73M | Sell |
|
|||||
|
2023
Q1 | $15.1M | Sell |
|
|||||
|
2022
Q4 | $34.8M | Sell |
|
|||||
|
2022
Q3 | $57.1M | Buy |
|
|||||
|
2022
Q2 | $38.6M | Buy |
|
|||||
|
2022
Q1 | $35.3M | Buy |
|
|||||
|
2021
Q4 | $17.9M | Sell |
|
|||||
|
2021
Q3 | $20.2M | Sell |
|
|||||
|
2021
Q2 | $27.1M | Sell |
|
|||||
|
2021
Q1 | $33.5M | Sell |
|
|||||
|
2020
Q4 | $59M | Buy |
|
|||||
|
2020
Q3 | $28M | Sell |
|
|||||
|
2020
Q2 | $45M | Buy |
|
|||||
|
2020
Q1 | $34M | Buy |
|
|||||
|
2019
Q4 | $32.3M | Sell |
|
|||||
|
2019
Q3 | $34.2M | Sell |
|
|||||
|
2019
Q2 | $95.7M | Buy |
|
|||||
|
2019
Q1 | $39.9M | Sell |
|
|||||
|
2018
Q4 | $64.1M | Sell |
|
|||||
|
2018
Q3 | $82.3M | Sell |
|
|||||
|
2018
Q2 | $69.4M | Sell |
|
|||||
|
2018
Q1 | $86.2M | Buy |
|
|||||
|
2017
Q4 | $97M | Buy |
|
|||||
|
2017
Q3 | $85.5M | Buy |
|
|||||
|
2017
Q2 | $74.5M | Buy |
|
|||||
|
2017
Q1 | $29.6M | Buy |
|
|||||
|
2016
Q4 | $33.1M | Sell |
|
|||||
|
2016
Q3 | $38.8M | Buy |
|
|||||
|
2016
Q2 | $23.5M | Buy |
|
|||||
|
2016
Q1 | $27.4M | Sell |
|
|||||
|
2015
Q4 | $86.5M | Buy |
|
|||||
|
2015
Q3 | $45.9M | Buy |
|
|||||
|
2015
Q2 | $54.2M | Sell |
|
|||||
|
2015
Q1 | $70.6M | Buy |
|
|||||
|
2014
Q4 | $27.7M | Sell |
|
|||||
|
2014
Q3 | $30.1M | Sell |
|
|||||
|
2014
Q2 | $26.8M | Buy |
|
|||||
|
2014
Q1 | $24.4M | Sell |
|
|||||
|
2013
Q4 | $23.4M | Buy |
|
|||||
|
2013
Q3 | $19.8M | Buy |
|
|||||
|
2013
Q2 | $11.8M | Buy |
|